Evaluation of miR-429 as a novel serum biomarker for pancreatic ductal adenocarcinoma and analysis its tumor suppressor function and target genes.

Huang, W-T; Lin, T-S; Wu, J-Y; Hong, J-M; Chen, Y-L; Qiu, F-N

Huang, W-T; Lin, T-S; Wu, J-Y; Hong, J-M; Chen, Y-L; Qiu, F-N.

Affiliation

Huang WT; Department of Hepatobiliary Surgery, Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China. drhuangwt@fjmu.edu.cn.

Eur Rev Med Pharmacol Sci ; 26(13): 4638-4653, 2022 07.

Article in En | MEDLINE | ID: mdl-35856354

Subject(s)

Carcinoma, Pancreatic Ductal; MicroRNAs; Pancreatic Neoplasms; Biomarkers; Carcinoma, Pancreatic Ductal/blood; Carcinoma, Pancreatic Ductal/diagnosis; Carcinoma, Pancreatic Ductal/genetics; Cell Line, Tumor; Cell Proliferation/physiology; Genes, Tumor Suppressor; Humans; MicroRNAs/blood; MicroRNAs/genetics; Pancreatic Neoplasms/blood; Pancreatic Neoplasms/diagnosis; Pancreatic Neoplasms/genetics

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Carcinoma, Pancreatic Ductal / MicroRNAs Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Eur Rev Med Pharmacol Sci Year: 2022 Document type: Article

Fulltext

XML

PubMed Links

Search on Google